Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Helping cancer patients make sense of risk

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant

Rare cancers and the difficulties in making clinical decisions

Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Study shows chemotherapy and radiotherapy are safe for babies in utero

Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy

New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Second-line afatinib significantly improves PFS in metastatic head and neck cancer

Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction

Current treatment options in mRCC